Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy AstraZeneca PLC ADR (AZN) shares in India

Learn how to easily invest in AstraZeneca PLC ADR shares.

AstraZeneca PLC ADR is a drug manufacturers-general business based in the US. AstraZeneca PLC ADR shares (AZN) are listed on the NASDAQ and all prices are listed in US Dollars. AstraZeneca PLC ADR employs 83,500 staff and has a trailing 12-month revenue of around USD$43.8 billion.

How to buy shares in AstraZeneca PLC ADR from India

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for AstraZeneca PLC ADR. Find the stock by name or ticker symbol: AZN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until AstraZeneca PLC ADR reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$72.52, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of AstraZeneca PLC ADR, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of AstraZeneca PLC ADR. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Compare online trading platforms

Name Product Number of stocks CFDs Shares Available Markets Link
Go to site
CFD service. Your capital is at risk.
CFD Service. Your capital is at risk.
Pay $0 fee on every trade in the stock market by opening a Libertex investment account. Start investing with just $50 and earn dividends from your stocks on the Libertex Portfolio platform.
ICICI Direct
All NSE/BSE listed stocks
Go to site
More info
Kickstart your investment journey with one of the largest retail stock brokers in India. Open a single 3-in-1 integrated account and trade a wide range of asset classes with ease.
Saxo Bank
Go to site
CFD service. Your capital is at risk.
More info
CFD Service. Your capital is at risk.
Trade 40,000+ financial instruments at market-leading prices with this powerful yet intuitive trading platform.
Zacks Trade
Access to global markets
Go to site
More info
Trade stocks, bonds, ETFs, options, and more on 90+ international exchanges. Offers customisable trading platforms with over 120 technical indicators for your charting needs.
Bajaj Finserv Securities
All NSE/BSE listed stocks
More info
Pay ₹5 per order brokerage on equities, futures and options trades by signing up to the Bajaj Privilege Club. T&Cs apply.
Bajaj Finserv Securities is one of the largest retail asset financing NBFCs in India offering a wide product portfolio

Is it a good time to buy AstraZeneca PLC ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

AstraZeneca PLC ADR shares at a glance

Information last updated 2023-05-24.
Latest market close$72.52
52-week range$51.90 - $76.56
50-day moving average $72.14
200-day moving average $65.95
Wall St. target price$79.43
PE ratio 48.245
Dividend yield $2.9 (1.95%)
Earnings per share (TTM) $1.51

AstraZeneca PLC ADR stock price (NASDAQ:AZN)

Use our graph to track the performance of AZN stocks over time.

AstraZeneca PLC ADR price performance over time

Historical closes compared with the close of $72.52 from 2023-05-26

1 week (2023-05-23) -2.09%
1 month (2023-04-28) -0.96%
3 months (2023-03-02) 11.40%
6 months (2022-11-30) 6.69%
1 year (2022-05-27) 7.60%
2 years (2021-05-28) 27.74%
3 years (2020-05-29) 32.82%
5 years (2018-05-30) 96.74%

Is AstraZeneca PLC ADR stock undervalued or overvalued?

Valuing AstraZeneca PLC ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AstraZeneca PLC ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

AstraZeneca PLC ADR financials

Revenue TTM $43.8 billion
Operating margin TTM 23.1%
Gross profit TTM $35.7 billion
Return on assets TTM 6.43%
Return on equity TTM 13.05%
Profit margin 10.73%
Book value $1.92
Market capitalisation $226.1 billion

TTM: trailing 12 months

AstraZeneca PLC ADR share dividends


Dividend payout ratio: 43.28% of net profits

Recently AstraZeneca PLC ADR has paid out, on average, around 43.28% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.95% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), AstraZeneca PLC ADR shareholders could enjoy a 1.95% return on their shares, in the form of dividend payments. In AstraZeneca PLC ADR's case, that would currently equate to about $2.9 per share.

While AstraZeneca PLC ADR's payout ratio might seem fairly standard, it's worth remembering that AstraZeneca PLC ADR may be investing much of the rest of its net profits in future growth.

AstraZeneca PLC ADR's most recent dividend payout was on 27 March 2023. The latest dividend was paid out to all shareholders who bought their shares by 23 February 2023 (the "ex-dividend date").

Have AstraZeneca PLC ADR's shares ever split?

AstraZeneca PLC ADR's shares were split on a 2:1 basis on 27 July 2015. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your AstraZeneca PLC ADR shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for AstraZeneca PLC ADR shares which in turn could have impacted AstraZeneca PLC ADR's share price.

AstraZeneca PLC ADR share price volatility

Over the last 12 months, AstraZeneca PLC ADR's shares have ranged in value from as little as $51.8968 up to $76.56. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AstraZeneca PLC ADR's is 0.1787. This would suggest that AstraZeneca PLC ADR's shares are less volatile than average (for this exchange).

AstraZeneca PLC ADR overview

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc, as well as research collaboration with Sernova Corp. to evaluate novel potential therapeutic cell applications. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site